Genome Editing: Technologies and Global Markets

Published - Mar 2019| Analyst - Mike (Ke Ke) Fan| Code - BIO146B
Genome Editing: Technologies and Global Markets
Single User License: $5500 Member Price: FREE

Report Highlights

The global market for genome editing should grow from $1.4 billion in 2018 to $4.4 billion by 2023, with a compound annual growth rate (CAGR) of 25.7% for the period of 2018-2023.

Report Includes

  • 44 tables
  • A comprehensive overview of the global markets and technologies for genome editing within the industry
  • Analyses of global market trends, with data from 2017, 2018, and projections compound annual growth rates (CAGRs) through 2023
  • Segmentation of the global market by geographical regions, product types, technology types and end-user application areas
  • Emphasis on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products
  • Current status on the intellectual property right of the CRISPR-Cas9 genome editing technology
  • Discussion of the ethical and regulatory issues, as well as patent analysis, publication analysis and research funding in this area
  • Profiles of key players in the industry, including Horizon Discovery, Thermo Fisher Scientific, CRISPR Therapeutics, Caribou Biosciences Inc., Editas Medicine and Vertex

Report Scope

This study is focused on the market side of genome editing and provides a comprehensive review of genome editing technologies, along with updates on the latest related progress in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and the Rest of World.

Specifically centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as each of its segments. It details recent technical breakthroughs as well as major technical issues to overcome before genome editing is applied to clinical applications. The growth driving factors and the factors that may limit the market’s growth are identified. The ethical issues, regulatory issues and intellectual property rights issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

Analyst Credentials

Mike Fan is a life science marketing and product management professional with more than 20 years of experience cover multiple biotech R&D areas, as well as life science marketing in both academia and industry. Mike has a broad range of technical skills in chemical and biological area and holds a PhD in Chemical Engineering and a Master of Business Administration focusing on Marketing.

Select reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Mar-2016| Analyst - Mike (Ke Ke) Fan| Code - BIO146A

Report Highlights

The global market for genome editing totaled $206.0 million in 2014 and $395.0 million in 2015. The market should total over $2.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 38.9% from 2015 to 2020.

Report Includes

  • An overview of the global markets and technologies for genome editing, a promising new approach that can overcome the shortcomings from site-directed mutagenesis and recombination based methods using relatively simple concepts.
  • Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • A focus on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products.
  • Breakdowns of the market by region, industry, application, product and type, technology, and end-user.
  • A look at the recent technical breakthrough on the use of CRISPR/Cas9 and how it has fueled the rapid growth of the genome editing industry.
  • A look at other growth driving factors including: the need of precision medicine for accurate genome editing technology; the increased R&D expenditure in related industrial sectors (e.g. biopharma, agriculture, and energy); increased funding for genomics research and its technological advancements; increasing demand for synthetic genes in synthetic biology; Concerns that genetically modified crops can be reduced by applying gene editing technologies to non-trangenic plant breeding.
  • Exploration of emerging ethical issues.
  • A relevant patent analysis.
  • Profiles of key players in the industry.
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report